These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

106 related items for PubMed ID: 5069487

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. [Clinical study on 20 gastroduodenal ulcer patients treated with 2-p-methyl sulphonylphenyl imidazol (1,2-alpha) pyridine (zolimidine)].
    García Alvarez M, Ramírez Armengol JA.
    Rev Clin Esp; 1972 Aug 31; 126(4):353-6. PubMed ID: 4638610
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Metabolic fate of Zolimidine. II. Analytical profile, tissue levels and urinary excretion in animals and in man.
    Picco S, Bonaldi A, Frigerio A, Danieli B, Almirante L.
    Farmaco Sci; 1974 Nov 31; 29(11):848-60. PubMed ID: 4442573
    [No Abstract] [Full Text] [Related]

  • 5. [Use of a new drug in the treatment of gastroduodenal diseases].
    Bagliani A, Borri P.
    Minerva Gastroenterol; 1972 Nov 31; 18(3):165-74. PubMed ID: 4614114
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. [Gastropathy caused by indomethacin and gastric protection with zolimidine. Physiopathogenetic interpretations and preliminary clinical notes].
    Sovera A, Volta A.
    Minerva Gastroenterol; 1974 Nov 31; 20(4):160-7. PubMed ID: 4459732
    [No Abstract] [Full Text] [Related]

  • 8. [Controlled clinical evaluation of the therapeutic activity of 3 antiulcer agents in peptic ulcer: carbenoxolone, proglumide and zolimidine].
    Fossati C.
    Clin Ter; 1979 Mar 31; 88(6):605-19. PubMed ID: 157245
    [No Abstract] [Full Text] [Related]

  • 9. [Experimental clinical study of the effectiveness of glycopeptide in gastroduodenal pathology].
    Vera Camba M, Villalgordo Aparicio C, Güemes Díaz F, Arias Vallejo E.
    Rev Esp Enferm Apar Dig; 1974 Mar 15; 43(2):225-34. PubMed ID: 4840489
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. [Zolimidine. Evaluation of the symptomatic effect in patients with gastroduodenal diseases].
    Rizzi B, Giacomini F, Bandini V.
    Minerva Gastroenterol; 1975 Mar 15; 21(4):258-65. PubMed ID: 778658
    [No Abstract] [Full Text] [Related]

  • 12. [Trial of a new drug in the treatment of gastroduodenal ulcer and gastrointestinal disorders].
    Bogazzi G, Fusco E.
    Minerva Gastroenterol; 1968 Mar 15; 14(4):258-64. PubMed ID: 5745806
    [No Abstract] [Full Text] [Related]

  • 13. [Proglumide in peptic ulcer and in gastroduodenal pathology. Clinical, biological and endoscopic study].
    Bennani A.
    Med Chir Dig; 1979 Mar 15; 8(4):351-6. PubMed ID: 502629
    [No Abstract] [Full Text] [Related]

  • 14. [Action of sultroponium in gastroduodenal pathology. Clinical and biological study].
    Ribet A, Frexinos J.
    Therapeutique; 1970 May 15; 46(5):511-3. PubMed ID: 5430223
    [No Abstract] [Full Text] [Related]

  • 15. [Clinical trial of sulpiride in digestive pathology].
    Négret JP.
    Bord Med; 1970 Jun 15; 3(6):1713-8. PubMed ID: 5433898
    [No Abstract] [Full Text] [Related]

  • 16. [Anti-secretory therapy of peptic ulcer with cimetidine and activation of the mucosal barrier with zolimidine: preliminary results of combined treatment].
    Assisi R, De Miranda B, De Stefano S.
    Clin Ter; 1980 Jun 15; 93(5):563-75. PubMed ID: 6448726
    [No Abstract] [Full Text] [Related]

  • 17. [Clinical trial of a new synthetic anticholinergic: 1290 CERM].
    Herne N, Parneix Y.
    Mars Med; 1969 Jun 15; 106(7):628-30. PubMed ID: 5399370
    [No Abstract] [Full Text] [Related]

  • 18. [Contribution of sulpiride in the surgery of gastroduodenal ulcer].
    René L.
    Therapeutique; 1970 May 15; 46(5):583-4. PubMed ID: 5430235
    [No Abstract] [Full Text] [Related]

  • 19. [Effect, on gastric absorption, of a new molecule with mucopoietic activity, 2-)p-methylsulfonylphenyl)-imidazo (1,2-a) pyridine, used in therapy of gastroduodenal diseases].
    Barlattani M.
    Clin Ter; 1971 Dec 15; 59(5):417-30. PubMed ID: 5159600
    [No Abstract] [Full Text] [Related]

  • 20. [Univocal treatment of multiform disorders: dogmatil in psycho-digestive pathology].
    Bernard J.
    Therapeutique; 1970 Mar 15; 46(3):336-7. PubMed ID: 5422205
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.